Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Getinge AB (GNGBY)
OTHER OTC:GNGBY
Holding GNGBY?
Track your performance easily
Earnings Data
Report Date
Jan 28, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
0.25Same Quarter Last Year
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 18, 2018
|% Change Since: -13.20%
|Next Earnings Date:Jul 17, 2018
Earnings Call Sentiment|Neutral
The earnings call depicted a mixed picture with strong order intake and strategic acquisitions, but significant challenges in gross margins, regulatory costs, and supply chain issues. The company maintained a strong financial position despite these challenges.Company Guidance
During the Getinge Q3 2024 earnings call, the company reiterated its guidance for the full year, projecting organic net sales growth between 2% and 5%, with recent acquisitions contributing an additional 3% to 5%. Key metrics from the quarter included a 10% increase in order intake, with 7.4% being organic growth. The net sales increased by 3.5%, although organic growth was flat compared to the previous year. The adjusted gross margin declined by 2.8 percentage points, influenced by a negative mix, inflation, and under-absorption, partially offset by price increases. Adjusted EBITA was SEK 903 million, with a margin of 11.5%, which was impacted by a 3 percentage point decrease due to a decline in the gross margin. The company also reported a free cash flow of around SEK 0.4 billion, and net debt stood at SEK 11.3 billion. Getinge remains focused on addressing challenges in acute care therapies and maintaining a solid financial position despite increased leverage following the acquisition of Paragonix Technologies.Strong Global Market Momentum
Order intake growth increased by 10%, with organic growth at 7.4%, showing positive development across all business areas except Life Science.
Sustainability and Quality Achievements
TÜV SÜD reinstated CE certificate for HLS and PLS consumables used for ECLS or ECMO therapy, and the U.S. Defense Health Agency certified the company's ventilators for cybersecurity.
Strategic Acquisitions
Acquired U.S.-based Intact Solution and completed acquisition of Paragonix Technologies, enhancing product offerings and market presence.
Positive Outlook for Order Intake
Order intake grew by 10% in the quarter, with strong performance in Americas driven by Acute Care Therapies and Surgical Workflows.
Financial Position Remains Solid
Despite increased financial leverage due to acquisitions, the financial position remains strong, with a net debt to EBITA leverage of 2x.
---
GNGBY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
GNGBY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 18, 2024 | $19.92 | $18.90 | -5.12% |
| Jul 18, 2024 | $17.75 | $19.64 | +10.65% |
| Apr 22, 2024 | $19.28 | $20.95 | +8.66% |
| Feb 01, 2024 | $21.40 | $18.66 | -12.80% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Getinge AB (GNGBY) report earnings?
Getinge AB (GNGBY) is schdueled to report earning on Jan 28, 2025, TBA Not Confirmed.
What is Getinge AB (GNGBY) earnings time?
Getinge AB (GNGBY) earnings time is at Jan 28, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GNGBY EPS forecast?
Currently, no data Available
---